Here is how Agilon Health (AGL) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
Source: https://www.zacks.com/stock/news/2904351/is-agilon-health-ag…
Brookfield Renewable expects to grow its cash flow per share at a more than 10% annual rate over the next five years. Enbridge can deliver 5% annual growth through the end of the decade.
Hims & Hers’ stock is up after ending its lawsuit with Novo Nordisk. The deal shows that industry power lies with the drugmakers.
Royal Caribbean posted mixed Q4 results, but shares rallied on its guidance. Cruise lines sail higher after the report.
